Medistep Healthcare last traded at ₹20.50 (2026-10-13). Over the past month the stock moved -12.4%, three months the stock moved +5.4%, year the stock moved -31.2%. Its closing range over 52 weeks is ₹16.50 – ₹29.80, with the latest close 31.2% below the high.
Closing prices up to 2026-10-13.
Incorporated in June 2023, Medistep Healthcare Ltd manufactures and trades healthcare and personal care products.[1]
Business Overview:[1] MHL is engaged in the business of manufacturing of sanitary pads and energy powder, as well as the trading and distribution of a wide range of healthcare products comprising pharmaceutical formulations, nutraceutical products, intimate care products, and surgical supplies.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 35.76 | 4.27 | 11.94 | 3.01 | 2.12 |
| Sep 2025 | 35.07 | 3.98 | 11.35 | 2.97 | 2.09 |
| Mar 2025 | 28.40 | 3.31 | 11.65 | 2.46 | 2.35 |
| Sep 2024 | 21.25 | 2.29 | 10.78 | 1.69 | 1.61 |
In the latest year (Mar 2026), Medistep Healthcare reported sales of ₹70.83 crore (+42.7%) and net profit of ₹5.98 crore (+44.4%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 70.83 | 8.25 | 11.65 | 5.98 | 4.21 |
| Mar 2025 | 49.65 | 5.61 | 11.30 | 4.14 | 3.96 |
| Mar 2024 9m | 31.60 | 3.96 | 12.53 | 2.91 | 5.94 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales growth | +57.1% | +42.7% |
| Operating profit growth | +41.7% | +47.1% |
| Net profit growth | +42.3% | +44.4% |
| EPS growth | -33.3% | +6.3% |
| OPM % | 11.3% | 11.7% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Medistep Healthcare.
Get Free AI Stock Analysis FREE →No recent news available for Medistep Healthcare.
Medistep Healthcare shares were last quoted at ₹20.50 (+0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Medistep Healthcare has a price-to-earnings (P/E) ratio of 5.11 and a price-to-book (P/B) ratio of 0.81. The industry P/E is 52.82.
The 52-week high of Medistep Healthcare is ₹32.85 and the 52-week low is ₹16.50.
The market capitalisation of Medistep Healthcare is about ₹30.55 crore.
This page is for information and is not investment advice. As per the data shown here, Medistep Healthcare has a 3-year ROE of 24.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 68.96% of Medistep Healthcare.
Medistep Healthcare belongs to the Pharmaceuticals & Drugs sector.